ACRS vs TT · rev $3.6M vs P/E 36, rev $11.32B
Aclaris Therapeutics Inc (ACRS) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported TT revenue for 2026-06-30 was $11.32B. Net income was $1.51B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
ACRS currently screens at market cap $615.9M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the ACRS and TT stock pages for the full models.
Not investment advice.